Anthropometric characteristics of elite athletes, recreationally active controls and HCM patients
| Athletes (n=18) | Controls (n=10) | HCM (n=18) | p Value | |
|---|---|---|---|---|
| Age (year) | 38±12 | 37±14 | 39±15 | 0.860 |
| Systolic blood pressure (mm Hg) | 127±13 | 124±12† | 139±15 | 0.018 |
| Diastolic blood pressure (mm Hg) | 71±9† | 70±7† | 87±9 | <0.001 |
| Height (cm) | 180±6† | 175±10 | 173±10 | 0.055 |
| Weight (kg) | 77±9 | 83±18 | 81±19 | 0.572 |
| Heart rate (beats/min) | 48±10*† | 63±15 | 70±10 | <0.001 |
| Current symptoms | 10/18 | |||
| SAM | 3/18 | |||
| LVOT | 2/18 | |||
| Medications | 11/18 |
Data are mean±SD for continuous variables.
Current symptoms, palpitation, chest pain, breathlessness, pre-syncope, syncope; HCM, hypertrophic cardiomyopathy; SAM, systolic anterior motion; LVOT, left ventricular outflow tract obstruction; medications, β blockers, ACE inhibitors, calcium channel blockers, antiarrhythmic agents.
Significantly different when post hoc tests are applied *compared to controls, †compared to HCM, p<0.05.